Argent Advisors’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $323K | Sell |
2,670
-193
| -7% | -$23.4K | 0.1% | 126 |
|
|
2025
Q1 | $319K | Buy |
2,863
+190
| +7% | +$21.2K | 0.11% | 126 |
|
|
2024
Q4 | $260K | Hold |
2,673
| – | – | 0.1% | 123 |
|
|
2024
Q3 | $307K | Sell |
2,673
-670
| -20% | -$77.1K | 0.11% | 114 |
|
|
2024
Q2 | $356K | Hold |
3,343
| – | – | 0.14% | 108 |
|
|
2024
Q1 | $323K | Buy |
3,343
+450
| +16% | +$43.5K | 0.13% | 111 |
|
|
2023
Q4 | $292K | Sell |
2,893
-410
| -12% | -$41.4K | 0.13% | 114 |
|
|
2023
Q3 | $336K | Hold |
3,303
| – | – | 0.15% | 103 |
|
|
2023
Q2 | $333K | Hold |
3,303
| – | – | 0.15% | 102 |
|
|
2023
Q1 | $304K | Buy |
3,303
+100
| +3% | +$9.2K | 0.15% | 106 |
|
|
2022
Q4 | $291K | Hold |
3,203
| – | – | 0.15% | 108 |
|
|
2022
Q3 | $243K | Buy |
3,203
+100
| +3% | +$7.59K | 0.14% | 114 |
|
|
2022
Q2 | $262K | Sell |
3,103
-23
| -0.7% | -$1.94K | 0.15% | 109 |
|
|
2022
Q1 | $274K | Hold |
3,126
| – | – | 0.15% | 118 |
|
|
2021
Q4 | $273K | Hold |
3,126
| – | – | 0.15% | 111 |
|
|
2021
Q3 | $256K | Buy |
3,126
+130
| +4% | +$10.6K | 0.15% | 111 |
|
|
2021
Q2 | $273K | Buy |
2,996
+300
| +11% | +$27.3K | 0.17% | 112 |
|
|
2021
Q1 | $230K | Sell |
2,696
-1,023
| -28% | -$87.3K | 0.15% | 119 |
|
|
2020
Q4 | $351K | Buy |
3,719
+118
| +3% | +$11.1K | 0.21% | 107 |
|
|
2020
Q3 | $313K | Buy |
3,601
+535
| +17% | +$46.5K | 0.21% | 104 |
|
|
2020
Q2 | $267K | Buy |
+3,066
| New | +$267K | 0.2% | 105 |
|
|
2020
Q1 | – | Sell |
-2,879
| Closed | -$272K | – | 378 |
|
|
2019
Q4 | $272K | Buy |
+2,879
| New | +$272K | 0.2% | 91 |
|